Compliance with mandatory reporting of clinical trial results on cross sectional study

BMJ 2012; 344 doi: (Published 3 January 2012)
Cite this as: BMJ 2012;344:d7373

Related articles

Editorial: Improving, and auditing, access to clinical trial results

Research: Non-publication of large randomized clinical trials: cross sectional analysis

Views & Reviews: Guidelines for collaboration with industry should be transparent

Head to Head: Are clinical trial data shared sufficiently today? No

Analysis: Restoring invisible and abandoned trials: a call for people to publish the findings

Letter: Don’t underestimate the extent of under-reporting

Analysis: Deficiencies in proposed new EU regulation of clinical trials

Research: Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration

Editorial: The new BMJ policy on sharing data from drug and device trials

News: Health minister agrees to meet academics to discuss access to clinical trial data

News: FDA given new powers over data reporting to national clinical trials registry

News: FDA disagrees with BMJ study that found clinical trials were not being reported

News: Congressmen demand faster publication of trial data after BMJ revealed long delays

Editorial: Missing clinical trial data

Paper: Publication bias: evidence of delayed publication in a cohort study of clinical research projects

See more

Research: Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis

Editorial: PSA screening for prostate cancer

Editorial: Does US health reform reduce hospital readmission rates?

This article has been cited by other articles: